This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Asahi Kasei Pharma Corporation, Vernalis (R&D) Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Tomohisa Toyama: Innovator in Medicinal Chemistry
Introduction
Tomohisa Toyama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with therapeutic potential. Although he currently holds no granted patents, his work continues to influence the industry.
Latest Patent Applications
One of Tomohisa Toyama's recent patent applications is for a macrocyclic compound. This compound is represented by the general formula (1) or a salt thereof, which exhibits superior IRAK-4 inhibitory activity. It is useful as an active ingredient in medicaments for the prophylactic and therapeutic treatment of diseases related to IRAK-4 inhibition.
Conclusion
Tomohisa Toyama's innovative work in medicinal chemistry highlights his commitment to advancing healthcare solutions. His contributions, particularly in the area of IRAK-4 inhibition, showcase the potential for future developments in this vital field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile